Pacific Biosciences of California, Inc. (PACB)

NASDAQ: PACB · USD

$2.82

+0.37 (+15.1%)· Recorded snapshot

Market cap	876.5M
Revenue (ttm)	159.3M
Net income (ttm)	-131.4M
EPS (ttm)	-$0.43
Shares out	310.8M
Volume	33,771,970
Beta	2.19

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 159.3M
Net income (ttm): -131.4M
EPS (ttm): -$0.43
Market cap: 876.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-929.3

P25 n/aP50 n/aP75 n/a

ROIC-15.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All PACB indicators

Market & fundamental data

Available fields

218

Groups with data

Currency

USD

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001299130
Company name	Pacific Biosciences of California, Inc.
Country	United States
Country code	US
CUSIP number	69404D108
Earnings date	2026-11-04
Earnings time	amc
Employees	485
Employees change	-90
Employees growth	-15.65%
Enterprise value	$1.3B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2000
In index	RUSSELL2000
Industry	Medical Devices
IPO date	2010-10-27
Is primary listing	Yes
Is SPAC	No
ISIN number	US69404D1081
Last 10-K release date	2026-02-25
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$876.5M
Market cap category	Small-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$2.82
Price currency	USD
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-28
Symbol	PACB
U.S. state	California
Website	https://www.pacb.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-15.28%
EV/EBITDA	6.84x
EV/Sales	8.56x
FCF / EV yield	-9.06%
FCF yield	-13.86%
Forward EV/Sales	8.01x
Forward P/S	5.23x
Industry forward P/E	19.74x
Industry P/E	39.16x
P/S ratio	5.59x
Price/EBITDA ratio	4.47x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-111.47%
EBITDA margin	125.05%
Gross margin	29.42%
Operating margin	-111.47%
Pretax margin	-81.97%
Profit margin	-82.49%
Profit per employee	$-270,901
Revenue per employee	$328,394
ROA	-14.07%
ROA (5Y)	-15.23%
ROCE	-25.99%
ROE	-929.32%
ROE (5Y)	-78.38%
ROIC	-15.42%
SBC / revenue	21.53%
Tax / revenue	0.52%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	-15.43%
Gross profit growth (Q)	-13.9%
Gross profit growth 3Y	-1.09%
Gross profit growth 5Y	0.73%
Net income growth years	0
Revenue growth	2.03%
Revenue growth (Q)	-1.91%
Revenue growth (QoQ)	4.92%
Revenue growth 10Y	5.87%
Revenue growth 3Y	2.91%
Revenue growth 5Y	8.52%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-5.4M
Depreciation and amortization	$376.7M
EBIT	$-177.5M
EBITDA	$199.2M
EPS	$-0.43
FCF per share	$-0.40
Financing cash flow	$3.2M
Free cash flow	$-123.4M
Free cash flow minus SBC	$-157.7M
Gross profit	$46.9M
Income taxes	$827,000
Investing cash flow	$120.9M
Net cash flow	$6M
Net income	$-131.4M
Operating cash flow minus SBC	$-152.3M
Operating income	$-177.5M
Revenue	$159.3M
Stock-based compensation	$34.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-4.88
Book value per share	$-0.11
Debt / EBITDA	3.39
Goodwill	$317.8M
Interest coverage	-24.22
Long-term assets	$413.2M
Long-term liabilities	$716.3M
Net cash (debt)	$-472.3M
Net cash / market cap	-53.03%
Net debt / EBITDA	2.37
Piotroski F-Score	3
Property, plant and equipment	$67.3M
Shareholders' equity	$-33.2M
Tangible book value	$-364.1M
Tangible book value per share	$-1.17
Total assets	$751.9M
Total cash	$236.9M
Total debt	$709.1M
Total liabilities	$785.1M
WACC	9.45%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.2
Current assets	$338.6M
Current liabilities	$68.8M
Current ratio	4.92
Inventory turnover	1.96
Net working capital	$37.3M
Quick ratio	3.89
Working capital	$269.8M
Working capital turnover	0.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-5.75%
Dividend yield	0%
Shareholder yield	-5.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-66.53%
10Y return CAGR	-10.37%
10Y total return	-66.53%
150-day SMA	$1.54
15Y price change	-30.1%
15Y return CAGR	-2.36%
15Y total return	-30.1%
1D price change	15.1%
1M price change	75.62%
1M total return	75.62%
1W price change	45.15%
1W total return	45.15%
1Y price change	36.12%
1Y return CAGR	36.15%
1Y total return	36.12%
20-day SMA	$2.27
200-day SMA	$1.61
3M price change	109.19%
3M total return	109.19%
3Y price change	-59.99%
3Y return CAGR	-26.31%
3Y total return	-59.99%
50-day SMA	$1.77
50-day SMA vs 200-day SMA	50over200
52-week high	$3.44
52-week high date	2026-10-06
52-week low	$1.07
52-week low date	2026-08-12
5Y price change	-88.85%
5Y return CAGR	-35.52%
5Y total return	-88.85%
6M price change	78.93%
6M total return	78.93%
All-time high	$53.69
All-time high date	2021-02-11
All-time low	$0.85
All-time low date	2025-05-28
Average true range (ATR)	$0.26
Average volume	17.7M
Beta (1Y)	0.85
Beta (2Y)	0.89
Beta (5Y)	2.19
Change from 52-week high	-17.9%
Change from 52-week low	163.55%
Change from all-time high	-94.7%
Change from all-time low	234.27%
Change from open	15.1%
Day's gap	0%
Dollar volume	$95.2M
High price	$3.06
Low price	$2.45
Monthly RSI	51.95
Open price	$2.45
Position in 52-week range	60.66%
Premarket change	0%
Premarket close	$2.45
Premarket price	$2.45
Premarket volume	26K
Previous close	$2.45
Price vs 150-day SMA	84.62%
Price vs 20-day SMA	25.16%
Price vs 200-day SMA	77.26%
Price vs 50-day SMA	60.64%
Relative volume	1.91
RSI	70.47
Sharpe ratio	0.75
Sharpe ratio (3Y)	0.18
Sharpe ratio (5Y)	0
Sortino ratio	1.28
Sortino ratio (3Y)	0.33
Sortino ratio (5Y)	0.06
Volume	33.8M
Weekly RSI	66.07
YTD price change	52.14%
YTD total return	52.14%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	304.2M
Float percentage	97.86%
Shares change (QoQ)	1.58%
Shares change (YoY)	5.75%
Shares held by insiders	1.02%
Shares held by institutions	59.59%
Shares outstanding	310.8M
Short % of float	15.53%
Short % of shares	15.19%
Short ratio	4.5 days

Other indicators

Additional ticker metrics that do not fit the primary research groupings.

Metric	Value
Page views	305

Deeper analysis on PACB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this PACB report

Is a complete PACB research report available?

No complete published report is available for Pacific Biosciences of California, Inc. (PACB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Pacific Biosciences of California, Inc. (PACB)

Price

Financial snapshot

Fair-value bridge

Latest news · PACB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PACB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on PACB

Frequently asked questions